Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
about
Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatryDistinguishing Between Depression and Dementia in Older Persons: Neuropsychological and Neuropathological CorrelatesPharmacological interventions for preventing post-traumatic stress disorder (PTSD)Subcortical volumetric abnormalities in bipolar disorderThe myth of schizophrenia as a progressive brain diseasePharmacotherapy for prevention of post-traumatic stress disorderAntidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis?Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadnessCreatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?Neuropeptides in depression: role of VGFNeuroendocrine dysregulation following early social deprivation in childrenPharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic reviewHippocampal volume in early onset depressionAerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health TreatmentIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderImplications of circadian rhythm and stress in addiction vulnerabilityBrain Structural Effects of Psychopharmacological Treatment in Bipolar DisorderMyalgic Encephalomyelitis: Symptoms and BiomarkersEvidence for the role of corticotropin-releasing factor in major depressive disorderMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesStress-induced deficits in cognition and emotionality: a role of glutamateCells, biomarkers, and post-traumatic stress disorder: evidence for peripheral involvement in a central diseaseScience to practice: translating automated brain MRI volumetry in Alzheimer's disease from research to routine diagnostic use in the work-up of dementiaDiabetes-associated depression: the serotonergic system as a novel multifunctional targetNeuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureA systems approach to stress, stressors and resilience in humansWnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behaviorThe Role of Hippocampal NMDA Receptors in Long-Term Emotional Responses following Muscarinic Receptor ActivationHippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation.Learning and Memory Performance After Withdrawal of Agent Abuse: A ReviewStress potentiates decision biases: A stress induced deliberation-to-intuition (SIDI) modelNeurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptineHow does electroconvulsive therapy work? Theories on its mechanismAcute neuroimmune modulation attenuates the development of anxiety-like freezing behavior in an animal model of traumatic brain injuryReversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppressionProteomic analysis of rat hippocampus exposed to the antidepressant paroxetineCan variation in hypothalamic-pituitary-adrenal (HPA)-axis activity explain the relationship between depression and cognition in bipolar patients?Epigenetics and psychoneuroimmunology: mechanisms and modelsCritical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adultsSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
P2860
Q21203922-78B54925-9E70-48A2-A2E2-6DA94051247FQ22299260-42481A4C-3BAA-4268-AEEE-E092ECC8E7D8Q22337441-9233DAFD-7A9F-4CF1-8A43-4D44E896D404Q23747500-F5B68B02-9E6E-4B9F-A9AC-7F6A40A9F84FQ24067152-BC360802-C78A-4B1D-99C5-F842F38C86F3Q24244707-8AB45F02-245F-4112-B96A-86389170218FQ24541513-C11566DC-B412-4C8C-9DCC-D8E4D44A174DQ24603838-B17ABB9E-E9F1-40B3-9EA8-175B741FB42DQ24631151-7FC659C3-6B53-41EB-9F6D-42ED6C84F47FQ24647788-68F213F1-8CE1-4B9D-8388-4D408DEF736EQ24654157-8D1460B5-40DA-4DD8-9E83-4CD3F16F4142Q24657469-20E3F1B0-D4F6-40C9-8483-75120D5A69D2Q24795618-EA8BE8AB-EC11-4310-BE90-816F680CAEFFQ26741515-9AD55DC1-866A-4201-9B05-4BC9DA979399Q26747511-71006455-8188-4D5C-B43A-BF86FAFC6843Q26766394-5F1A69A2-585D-4D6F-9ABB-72F00C66B14DQ26786245-F6EC2E76-6094-47AB-BDC0-781544AE3372Q26786545-3E09A3D6-51FC-4934-8243-9D33E3722B77Q26798878-75D060D4-68F3-4A60-B52B-2FA3C025FAB8Q26799013-986DB41B-B882-4508-9174-C0731F2C861FQ26825021-D251D8D7-E1A0-4D23-A859-1671E59406FDQ26830476-32EECD29-745C-466D-A3C7-AA139CA05EEEQ26859565-1EDA364D-7AA6-4082-8FB6-D24158C7DAA6Q26864574-1FD953D1-9E2E-485D-9B48-29B67E1DC0DAQ26864905-ACBA963E-F01A-4612-8018-B65B049DAD54Q27006797-6171FFAA-835F-4821-9870-CEB93315AD9EQ27008843-A07A7851-03F0-4957-98D8-973EC7EE9953Q27329061-3EFD25BC-877F-420B-B23A-D90D22C73A7BQ27687034-D1FED8D5-5D4C-4B7F-92D4-4C2360A5985DQ28071392-84579A6E-B02A-46E1-AAE8-4A05F8A1C164Q28080172-371EA0FA-5A1D-4B9B-AC22-97AA27047700Q28238686-41820CF4-44CF-43DE-9AF6-16A80EEC42A7Q28305439-783F3693-1B25-43C9-96D6-5978A28AC35BQ28386168-1DF225E2-03AB-47E2-9742-9410327C25E6Q28396598-46B463D0-F498-4791-B7A2-4B1CB89ADAE8Q28567997-59A5E6D3-4AF2-4A5D-82E4-ED0AD98875C9Q28729989-5068B01B-CEA7-498A-91D1-452A97DE8585Q28748164-4F06995E-6011-42C8-B48C-2497481C2D04Q28764080-D364937B-A762-496D-9CDE-D2C949F5CEF0Q29615696-92A4B5D1-D26A-475F-A074-81835E75CB1D
P2860
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
@ast
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
@en
type
label
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
@ast
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
@en
prefLabel
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
@ast
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
@en
P1433
P1476
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
@en
P2093
Sapolsky RM
P304
P356
10.1001/ARCHPSYC.57.10.925
P407
P577
2000-10-01T00:00:00Z